BeStock  
Stocks › Biotechnology › JAZZ

Jazz Pharmaceuticals JAZZ

US equityMarket cap rank #676Biotechnology
$233.27 +$1.75 (+0.76%)
Market open · Oct 1, 11:50 am ET · After hours $227.76 -1.62%
Open$230.33
Prev close$231.52
Day range$229.93 – $234.06
Volume202.5K
Market cap$15.14B
P/E (TTM)16.0
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.21B+15.5% YoY
Operating profit$325.20M+48.5% YoY
Net profit$192.80M+126.8% YoY
Diluted EPS$2.78+123.7% YoY
Free cash flow$243.40M+220.7% YoY
Operating cash flow$415.70M

Revenue, last 8 quarters

$1.1BSep '24$1.1BDec '24$897.8MMar '25$1.0BJun '25$1.1BSep '25$1.2BDec '25$1.1BMar '26$1.2BJun '26

Net profit, last 8 quarters

$215.1MSep '24$191.1MDec '24$-92.5MMar '25$-718.5MJun '25$251.4MSep '25$203.5MDec '25$293.1MMar '26$192.8MJun '26

Diluted EPS by quarter

3.42Sep '243.11Dec '24-1.52Mar '25-11.74Jun '254.08Sep '253.21Dec '254.43Mar '262.78Jun '26

Free cash flow by quarter

$388.0MSep '24$385.3MDec '24$390.9MMar '25$75.9MJun '25$386.9MSep '25$292.3MDec '25$388.5MMar '26$243.4MJun '26

Annual revenue

$2.4BFY20$3.1BFY21$3.7BFY22$3.8BFY23$4.1BFY24$4.3BFY25

Profitability & balance sheet

Gross margin88.4%
Operating margin22.1%
Net margin20.4%
Return on equity22.1%
Return on assets8.5%
Return on invested capital11.4%
Current ratio1.78
Liabilities / assets56.7%
Cash & investments$2.20B
Total debt$4.40B
Net cash (debt)-$2.20B
Free cash flow / sales28.5%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.21B $1.07B $4.27B $1.20B $1.13B
Total Operating Revenue $1.21B $1.07B $4.27B $1.20B $1.13B
Cost of Revenue $116.40M $134.10M $503.30M $153.53M $128.88M
Gross Profit $1.09B $934.80M $3.76B $1.04B $997.23M
Operating Expense $766.70M $598.20M $3.25B $789.86M $897.22M
Selling and Admin Expenses $389.20M $352.70M $1.81B $406.21M $530.65M
Research & Development $207.50M $196.00M $782.74M $213.91M $198.20M
Depreciation & Amortization & Depletion $170.00M $172.30M $654.66M $169.74M $168.37M
-Depreciation & Amortization $170.00M $172.30M $654.66M $169.74M $168.37M
Operating Profit $325.20M $336.60M $517.62M $254.54M $100.01M
Net Non-Operating Interest Income (Expense) -$37.10M -$39.90M -$195.05M -$45.41M -$48.58M
Non-Operating Interest Expense $37.10M $39.90M $195.05M $45.41M $48.58M
Other Income (Expense) -$77.10M $2.50M -$950.43M -$658,000.00 -$42.40M
Gain on Sale of Security -$100,000.00 $2.50M -$2.57M -$658,000.00 $102,000.00
Special Income (Charges) -$77.00M – -$947.86M $0.00 -$42.50M
-Less:Other Special Charges $77.00M – $947.86M $0.00 $42.50M
Pretax Profit $211.00M $299.20M -$627.86M $208.47M $9.04M
Tax $18.10M $6.10M -$272.44M $4.96M -$242.42M
Earnings from Equity Interest Net of Tax -$100,000.00 $0.00 -$732,000.00 -$57,000.00 -$47,000.00
Net Profit $192.80M $293.10M -$356.15M $203.45M $251.41M
Profit from Continuing Operations $192.80M $293.10M -$356.15M $203.45M $251.41M
Net Income to Parent Company $192.80M $293.10M -$356.15M $203.45M $251.41M
Net Income to Common Stockholders $192.80M $293.10M -$356.15M $203.45M $251.41M
Basic EPS $3.05 $4.73 -$5.84 $3.33 $4.14
Diluted EPS $2.78 $4.43 -$5.84 $3.21 $4.08
Other Operating Expenses – -$122.80M – – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $11.08B $11.86B $11.66B $11.66B $11.36B
Total Current Assets $3.97B $4.58B $4.17B $4.17B $3.76B
Cash and Cash Equivalents & Short-Term Investments $2.20B $2.87B $2.44B $2.44B $2.05B
-Cash and Cash Equivalents $1.62B $1.84B $1.39B $1.39B $1.33B
-Short Term Investments $580.00M $1.03B $1.05B $1.05B $720.00M
Receivables $880.90M $836.30M $830.75M $830.75M $764.36M
-Accounts Receivable $880.90M $836.30M $830.75M $830.75M $764.36M
Prepaid Assets $200.00M $149.70M $152.48M $152.48M $146.89M
Inventory $443.00M $437.50M $416.96M $416.96M $483.11M
Other Current Assets $244.50M $285.30M $323.95M $323.95M $315.44M
Total Non-Current Assets $7.11B $7.28B $7.49B $7.49B $7.60B
Net PPE $264.10M $258.90M $258.74M $258.74M $250.12M
-Gross PPE $454.60M $440.60M $437.29M $437.29M $421.33M
-Accumulated Depreciation -$190.50M -$181.70M -$178.55M -$178.55M -$171.21M
Goodwill and Other Intangible Assets $5.83B $6.01B $6.26B $6.26B $6.39B
-Goodwill $1.80B $1.81B $1.83B $1.83B $1.83B
-Other Intangible Assets $4.03B $4.20B $4.43B $4.43B $4.57B
Non-Current Deferred Assets $933.00M $914.10M $876.68M $876.68M $854.20M
Other Non-Current Assets $86.30M $94.70M $99.03M $99.03M $103.07M
Total Liabilities $6.28B $7.33B $7.34B $7.34B $7.40B
Total Current Liabilities $2.23B $2.25B $2.24B $2.24B $2.27B
Payables $184.40M $193.70M $178.45M $178.45M $243.37M
-Accounts Payable $128.50M $100.00M $122.06M $122.06M $152.23M
-Total Tax Payable $55.90M $93.70M $56.39M $56.39M $91.14M
Current Accrued Expenses $858.10M $790.20M $773.47M $773.47M $802.39M
Short-Term Debt and Capital Lease Obligation $1.03B $1.05B $1.04B $1.04B $1.04B
-Current Debt $1.02B $1.03B $1.03B $1.03B $1.03B
-Current Capital Lease Obligation $14.30M $14.90M $14.72M $14.72M $13.94M
Current Provisions $28.70M $26.60M $26.41M $26.41M $31.32M
Other Current Liabilities $8.60M $8.50M $4.23M $4.23M $5.10M
Total Non-Current Liabilities $4.05B $5.08B $5.10B $5.10B $5.12B
Long Term Debt and Capital Lease Obligation $3.38B $4.37B $4.38B $4.38B $4.39B
-Long Term Debt $3.34B $4.32B $4.33B $4.33B $4.33B
-Long Term Capital Lease Obligation $43.60M $47.30M $50.89M $50.89M $53.43M
Non-Current Deferred Liabilities $528.90M $547.70M $594.47M $594.47M $629.03M
Other Non-Current Liabilities $140.90M $161.50M $124.52M $124.52M $108.91M
Total Equity $4.80B $4.53B $4.32B $4.32B $3.96B
Stockholders' Equity $4.80B $4.53B $4.32B $4.32B $3.96B
Capital Stock $100,000.00 $100,000.00 $61,000.00 $61,000.00 $61,000.00
-Common Stock $100,000.00 $100,000.00 $61,000.00 $61,000.00 $61,000.00
Additional Paid-In Capital $4.33B $4.24B $4.24B $4.24B $4.09B
Retained Earnings $1.13B $939.20M $646.18M $646.18M $442.73M
Gains/Losses Not Affecting Retained Earnings -$662.50M -$651.00M -$568.60M -$568.60M -$569.90M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $415.70M $408.20M $1.36B $362.52M $474.66M
Net cash flow from continuing operations $415.70M $408.20M $1.36B $362.52M $474.66M
Net Income from Continuing Operations $192.80M $293.10M -$356.15M $203.45M $251.40M
Depreciation & Depletion & Amortization $179.10M $181.40M $696.30M $179.17M $178.33M
Deferred Tax -$38.70M -$66.20M -$444.97M -$63.31M -$271.36M
Other Non-Cash Items $218.90M -$76.70M $1.13B $40.98M $89.18M
Change in Working Capital -$94.40M -$12.10M $18.90M -$72.74M $130.84M
-Change in Receivables -$44.90M -$6.50M -$106.28M -$65.81M -$50.97M
-Change in Inventory -$29.90M -$77.80M -$86.04M $7.72M -$31.86M
-Change in Prepaid Assets $4.90M $51.90M $29.03M $27.49M -$18.36M
-Change in Payables and Accrued Expense -$700,000.00 $8.10M $154.17M -$37.59M $201.36M
-Change in Other Current Liabilities -$23.80M $12.20M $28.02M $29.09M -$2.97M
Net cash flow from investing $354.90M $123.10M -$1.51B -$372.16M -$327.75M
Net Cash Flow from Continuing Investing Activities $354.90M $123.10M -$1.51B -$372.16M -$327.75M
Net PPE Purchase and Sale -$18.10M -$19.70M -$58.75M -$16.73M -$15.22M
Net Intangibles Purchase and Sale -$154.20M $0.00 -$151.00M -$53.50M -$72.50M
Net Investment Purchase and Sale $250.00M $220.00M -$470.28M -$330.10M -$240.08M
Net Other Investing Changes $277.20M -$77.20M $28.17M $886.22M –
Financing Cash Flow -$994.50M -$78.50M -$873.38M $75.44M -$10.92M
Net Cash Flow from Continuing Financing Activities -$994.50M -$78.50M -$873.38M $75.44M -$10.92M
Net Issuance Payments Of Debt -$1.01B -$7.80M -$781.00M -$7.75M -$7.75M
Proceeds from Stock Option Exercised $22.70M $32.90M $107.86M $85.19M $677,000.00
Net Other Financing Charges -$9.50M -$103.60M -$75.22M -$2.00M -$3.82M
Ending Cash Balance $1.62B $1.84B $1.39B $1.39B $1.33B
Net Change in Cash -$223.90M $452.80M -$1.03B $65.80M $135.98M
Beginning Cash Balance $1.84B $1.39B $2.41B $1.33B $1.19B
Effect of Exchange Rate Changes -$600,000.00 -$400,000.00 $6.56M $33,000.00 $222,000.00
Free Cash Flow $243.40M $388.50M $1.15B $292.29M $386.93M
Net Business Purchase and Sale – – -$858.05M – –
Net Common Stock Issuance – – -$125.02M $0.00 -$23,000.00

Discussion

No comments yet — be the first to weigh in on JAZZ.

Leave a comment

Scroll to Top